Important Issues about Cord Blood Cell Research and Treatment

Cord blood cell research continues to be an interesting issue among practitioners in the medical field. For such a long time, brilliant medical experts have been studying the utilization of stem cells in the said blood in terms treating chronic conditions and life-threatening ailments.

Stem cells contain life-giving components that are essential in treating a myriad of detrimental conditions and cord blood stem cell research brought hope as well as a myriad of controversies. To understand them, it would be best to read this article.

Brief history

Matthew Kaufman, Martin Evans, and Gail Martin are the pioneers of cord blood stem cell research. The three experts discovered that cord blood stem cells are toti-potent or have the capacity to branch out and produce different body cells. If transplanted into the human body, it can take up the attributes of different stem cells and therefore control or stop the damages of chronic conditions.

Ethics

Despite its wide array of benefits, cord blood stem cell researches have become quite controversial in the past because the acquisition of cord blood cells destroys live embryos, read more Provacyl Reviews. The embryo is a body part that if made inside a womb has the potential to produce human life. To be used for cord blood stem cell transplantation, the embryo needs to be collected and this action can deprive an individual of his/her moral rights.

The thing that somewhat compensates for the collection of the embryo is the benefits that can be attained through cord blood transplants. On the other hand, many antagonists believe that they taking a human life to save another are not a worthy cause and adult stem cells should be used as alternatives. However, compared to adult stem cells, embryos have superior attributes since they can divide faster, are more flexible, and are more capable of treating life-threatening conditions.

Recently, controversies hounding the said issue have been reduced because of a procedure that acquires cord blood stem cells without harming the embryo.

In the process, a small amount of cord blood is attained in the delivery process and is stored in a cord blood bank where its beneficial attributes are preserved. It can be easily retrieved by patients for future treatments. The said option is very advantageous, but it comes with a steep price since patients need to pay storage facilities for their services.

Conclusion

Because of innovations in the medical science field, there are certainly lots in store for cord blood stem cells research. Certainly, future treatments will be safer and more effective in treating a myriad of detrimental conditions.